Sudeep Pharma IPO: Details And Fund Utilisation
-
New Issue: ₹95 crore
-
Offer for Sale: -1.35 crore shares, totaling ₹800 crore from promoters
-
Funds from fresh issue (₹75.81 crore) to be used for:
-
Capital expenditure at Nandesari Facility 1, Gujarat
-
General corporate purposes
-
Sudeep Pharma IPO Price, Allocation & Subscription Status At A Glance
| Category | Details |
|---|---|
| IPO Price Band | ₹563–593 per equity share |
| Allocation | QIB: Up to 50% NII: At least 15% Retail Investors: Minimum 35% |
| IPO Subscription Status | Overall: 1.42x Retail portion: 1.50x NII portion: 48% QIB portion: 3.00x |
| Total Bids Received | 1,50,09,425 shares against 1,05,64,926 shares offered |
Sudeep Pharma IPO: Grey Market Premium (GMP) and Expected Listing Price
- IPO GMP Today: ₹121
- Estimated listing price: ₹714 (20.40% higher than ₹593 upper price band)
- Grey market shows upward trajectory with GMP range: ₹0–130
(With Inputs)
Aishwarya is a journalism graduate with over three years of experience thriving in the buzzing corporate media world. She’s got a knack for decoding business news, tracking the twists and turns of the stock market, covering the masala of the entertainment world, and sometimes her stories come with just the right sprinkle of political commentary. She has worked with several organizations, interned at ZEE and gained professional skills at TV9 and News24, And now is learning and writing at NewsX, she’s no stranger to the newsroom hustle. Her storytelling style is fast-paced, creative, and perfectly tailored to connect with both the platform and its audience. Moto: Approaching every story from the reader’s point of view, backing up her insights with solid facts.
Always bold with her opinions, she also never misses the chance to weave in expert voices, keeping things balanced and insightful. In short, Aishwarya brings a fresh, sharp, and fact-driven voice to every story she touches.
